Nora Apothecary Recalls Hydroxycobalamin Injections Due to Sterility Concerns
Nora Apothecary is recalling Hydroxycobalamin Injections because FDA inspections raised concerns about quality control and sterility assurance.
The agency’s classification
FDA (Drugs): Class II
Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 4/5 (Severe).
The hazard poses a serious risk of illness, injury, or structural failure. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classified this as an FDA Class II recall. According to the rubric, FDA Class II recalls involving significant risks such as sterility issues in injectable drugs are categorized as Severe.
Plain-English summary
Nora Apothecary and Alternative Therapies, Inc. is recalling Hydroxycobalamin Inj 1000mcg/ml MDV in 10 ml, 15 ml, 20 ml, and 30 ml vials. The recall is due to FDA inspection findings that resulted in concerns regarding quality control processes and the assurance of sterility.
The recall covers 7 units of the product distributed nationwide. The affected products are those within their expiration date, including those dated 90 days prior to April 19, 2013 (January 2013 to April 19, 2013).
Consumers and healthcare providers should stop using the recalled product and contact the recalling firm for further instructions.
The recalled product
- Product
- Hydroxycobalamin Inj 1000mcg/ml MDV: 10 ml, 15 ml, 20 ml, 30 ml Subcutaneous, 90 day expiration,
- Manufacturer
- Nora Apothecary and Alternative Therapies, Inc.
- Category
- Drug — Injectable
- Hazard
- Affected units
- 7
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- 2013 (Jan. 2013 to April 19
- 2013).
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 43 recalled by Nora Apothecary and Alternative Therapies, Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 43 products in this recall →Related recalls
Same manufacturer · Nora Apothecary and Alternative Therapies, Inc.
See all →- SevereNora Apothecary Recalls PGE-1 Penile Injections Due to Sterility Concerns
FDA (Drugs) · 2013-06-05
- SevereNora Apothecary Recalls Chlorhexidine Ophthalmic Solution Due to Sterility Concerns
FDA (Drugs) · 2013-06-05
- SevereNora Apothecary Recalls Super Trimix Penile Injection Due to Sterility Concerns
FDA (Drugs) · 2013-06-05
- SevereNora Apothecary Recalls Bimix Inj 30:1 Syringes Due to Sterility Concerns
FDA (Drugs) · 2013-06-05
- SevereNora Apothecary Recalls Methylcobalamin Injections Due to Sterility Concerns
FDA (Drugs) · 2013-06-05
Same hazard · sterility
See all →- HighFDA recalls injectable compounded mixture in single-use syringes
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Semaglutide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereFDA Recalls Tirzepatide/Cyanocobalamin Injectable Due to Sterility Concerns
FDA (Drugs) · 2026-10-14
- SevereK.C. Pharmaceuticals Recalls Leader Advanced Relief Eye Drops for Sterility Concerns
FDA (Drugs) · 2026-10-14
Similar recalls
- SevereHydroxocobalamin Injection Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- SevereHydroxocobalamin Injection Recalled for Sterility Assurance Concerns
FDA (Drugs) · 2015-09-23
- SevereNatures Pharmacy Recalls Hydroxocobalamin Injections Due to Sterility Concerns
FDA (Drugs) · 2014-03-12
- SevereHydroxocobalamin Injection Recalled Due to Failed Sterility Testing
FDA (Drugs) · 2013-09-25
- SevereRXQ Compounding Recalls Hydroxocobalamin Injections Due to Sterility Concerns
FDA (Drugs) · 2019-08-14
- SevereHydroxocobalamin Injectable Recalled Due to Sterility Assurance Concerns
FDA (Drugs) · 2014-01-22